Bio-equivalent test mandatory for tablets, capsules and suppositories

Published: 2003-12-17 06:59:00

Updated: 2003-12-17 06:59:00

The KFDA is going to establish a standard bio-equivalent test guideline for 75 ingredients including Phenytoin in order to save test costs and times, and to require for the solid prescription preparations such as tablets, capsules and suppositories to get the bio-equivalent test from July next ye...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK